Haupt E, Herrmann R, Benecke-Timp A, Vogel H, Hilgenfeldt J, Haupt A, Walter C
Saale-Klinik der BfA, Bad Kissingen, Germany.
Exp Clin Endocrinol Diabetes. 1996;104(5):370-7. doi: 10.1055/s-0029-1211470.
% of type I diabetics are not administering insulin according to the intensified conventional therapy schedules, only 16.8% of all type II diabetics are treated with diet only. Type II diabetics are much too often treated with pre-mixed insulins of too high dosage (26.2%) or with oral hypoglycemics (46.2%) of which 90% were sulphonylureas and nearly exclusively glibenclamide. Oral hypoglycemics with extrapancreatic activity or combined therapies were not common among the patients.
Ⅰ型糖尿病患者中未按照强化常规治疗方案注射胰岛素的比例，在所有Ⅱ型糖尿病患者中，只有16.8%仅接受饮食治疗。Ⅱ型糖尿病患者常常接受剂量过高的预混胰岛素治疗（26.2%）或口服降糖药治疗（46.2%），其中90%为磺脲类药物，几乎全是格列本脲。具有胰腺外活性的口服降糖药或联合治疗在患者中并不常见。
